These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16681095)

  • 1. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].
    Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
    Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095
    [No Abstract]   [Full Text] [Related]  

  • 2. Citalopram (Celexa) and QT interval prolongation.
    Med Lett Drugs Ther; 2012 Sep; 54(1398):71-2. PubMed ID: 22992488
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribe escitalopram instead of citalopram.
    Keller DL
    Am J Med; 2013 Jun; 126(6):e21. PubMed ID: 23684405
    [No Abstract]   [Full Text] [Related]  

  • 4. The reply.
    Vieweg WV; Hasnain M; Howland RH
    Am J Med; 2013 Jun; 126(6):e23. PubMed ID: 23684406
    [No Abstract]   [Full Text] [Related]  

  • 5. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
    Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations on safety concerns about citalopram prescribing.
    Sheeler RD; Ackerman MJ; Richelson E; Nelson TK; Staab JP; Tangalos EG; Dieser LM; Cunningham JL
    Mayo Clin Proc; 2012 Nov; 87(11):1042-5. PubMed ID: 23018033
    [No Abstract]   [Full Text] [Related]  

  • 8. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
    Hussaarts KGAM; Berger FA; Binkhorst L; Oomen-de Hoop E; van Leeuwen RWF; van Alphen RJ; Mathijssen-van Stein D; de Groot NMS; Mathijssen RHJ; van Gelder T
    Pharm Res; 2019 Dec; 37(1):7. PubMed ID: 31845095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT; Lee Y; Lin YE; Lin PY
    Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged QTc interval and torsades de pointes induced by citalopram.
    Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K
    Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Petry N; Lupu R; Gohar A; Larson EA; Peterson C; Williams V; Zhao J; Wilke RA; Hines LJ
    Pharmacogenomics; 2019 Apr; 20(5):343-351. PubMed ID: 30983508
    [No Abstract]   [Full Text] [Related]  

  • 12. Citalopram, escitalopram, and the QT interval.
    Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
    [No Abstract]   [Full Text] [Related]  

  • 13. Should We be Worried About QTc Prolongation Using Citalopram? A Review.
    Hutton LMJ; Cave AJ; St-Jean R; Banh HL
    J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram--a risk factor for postoperative hyponatraemia.
    Holland S; Townley S; Summerfield R
    Anaesthesia; 2003 May; 58(5):491-2. PubMed ID: 12694018
    [No Abstract]   [Full Text] [Related]  

  • 15. A critical evaluation of the cardiac toxicity of citalopram: part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inappropriate antidiuretic hormone secretion syndrome and citalopram].
    Berrocal E; Esteban C; Delgado V; Ruiz-Rivas JL; Fraga MI
    Med Clin (Barc); 1999 Jan; 112(2):78. PubMed ID: 10065438
    [No Abstract]   [Full Text] [Related]  

  • 17. A case report of hyponatremia with citalopram use.
    Iraqi A; Baickle E
    J Am Med Dir Assoc; 2004; 5(1):64-5. PubMed ID: 14726801
    [No Abstract]   [Full Text] [Related]  

  • 18. A question about the potential cardiac toxicity of escitalopram.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citalopram should not be the first choice].
    Bergmark T
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1342. PubMed ID: 16708865
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressants and QTc prolongation.
    Lam RW
    J Psychiatry Neurosci; 2013 Mar; 38(2):E5-6. PubMed ID: 23422053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.